INTRODUCTION
Echinococcosis is an infectious disease caused by the larval (metacestode) stages of various cestode (tapeworm) species of the genus Echinococcus. Two of these parasite species are of medical and public health importance in that they are widely prevalent and may cause severe disease in humans: Echinococcus granulosus is the causative agent of cystic echinococcosis, or cystic hydatid disease; and E. multilocularis in humans causes alveolar echinococcosis, or alveolar hydatid disease. Two other species of the genus Echinococcus, namely, E. vogeli and E. oligarthrus, are mainly restricted to sylvatic animals and occur in some areas of Central and South America. As cases of the so-called polycystic echinococcosis (E. vogeli) are very rare in humans and cases of infections with E. oligarthrus have not been reported yet, these two parasite species will not be considered in the following text. A brief characterization of organisms causing echinococcosis is given in Table 1 .
Biology of E. granulosus and E. multilocularis E. granulosus is a small tapeworm (rarely exceeding 7 mm in length) that lives firmly attached to the mucosa of the small intestine in definitive hosts, usually dogs but occasionally other carnivores. Ungulates are intermediate hosts for E. granulosus. E. multilocularis occurs mainly in red and arctic foxes, but dogs and cats can incidentally be involved in the life cycle as definitive hosts (124) . Small mammals (microtine and arvicolid rodents, occasionally muskrats, and others) are intermediate hosts for E. multilocularis.
For both Echinococcus species, sexual maturity of the adult-stage tapeworms is reached within 4 to 5 weeks. This is followed by the shedding of gravid proglottids (each containing several hundred eggs) or released eggs in the feces of definitive hosts. Following ingestion of Echinococcus eggs by susceptible intermediate hosts and humans, a larva, the oncosphere, is released from the egg envelope. The oncosphere penetrates through the intestinal epithelium into the lamina propria and is passively transported through blood or lymph vessels to primary target organs such as liver and lungs or, less frequently, to other organs. At these locations, the metacestode stage of the parasite develops. Protoscolices form, and they grow to the adult stage once ingested by a definitive host.
The life cycles of E. granulosus and E. multilocularis are shown in Fig. 1 and 2.
Geographic Distribution
Infections with E. granulosus occur worldwide. A socalled European form (100) , primarily involving synanthropic hosts in its cycle, has a nearly cosmopolitan distribution. This form is responsible for major public health or economic problems in many rural areas of the world. A Northern form (100) is prevalent in northern parts of North America and Eurasia. Areas of endemicity are mainly related to tundra and taiga and are delineated by the southern limits of the boreal forest.
E. multilocularis seems to occur only in the northern hemisphere. In North America, the cestode is present in the subarctic regions of Alaska and Canada, including St. Lawrence Island (101) and some other islands (100) . The parasite has been discovered in Manitoba, Canada, and North Dakota (78) and, more recently, in Alberta and Saskatchewan, Canada, and Illinois, Nebraska (12), Iowa, South Dakota, Montana, Wyoming, and even South Carolina (73) , thus indicating an apparent expansion of the focus within the north central American continent. In Europe, areas with relatively frequent reports of alveolar echinococcosis in humans encompass central and eastern France, Clinical Manifestations E. granulosus. In cystic echinococcosis (hydatidosis) of humans, well-delineated spherical primary cysts are formed most frequently in the liver (approximately 65% of the cases) (Fig. 3 ), but also in the lungs (25%) and other organs such as kidney, spleen, brain, heart, and bone (110) . Cysts cause pathological damage or dysfunction mainly by the gradual process of space-occupying repression or displacement of vital host tissue, vessels, or organs. Consequently, clinical manifestations are primarily determined by the site and number of cysts and are quite variable. Accidental rupture of cysts can be followed by a massive release of cyst fluid and dissemination of protoscolices, resulting occasionally in anaphylactic reactions and/or multiple secondary cystic echinococcosis, since protoscolices have the potential of developing into cysts within the intermediate host. Successful surgical removal of hydatid cysts is frequent, so case fatality rates are low (varying between 1 and 4% for cases with first surgical intervention [110] ), provided modern medical facilities are available. The public health importance is mainly reflected by the number of infected persons and their diminished capacities, the direct and indirect costs of hospitalization and recovery from surgery, and any residual disability or clinical sequelae (116) . Globally, few data on the overall prevalence of human cystic echinococcosis exist. Regions with good documentation of prevalence include the whole Mediterranean area, the Turkana district of Kenya, large foci in South America, and many other zones in all continents. North American experiences have been documented by various groups (24, 29, 76, 112 ). An updated summary of cases in countries of the European Community and the European Free Trade Association has recently been presented (123) . E. multilocularis. E. multilocularis metacestodes (larvae) in humans are found almost exclusively in the liver, but secondary lesions can form in the lungs, brain, and other organs (110) . The hepatic lesion usually consists of a dispersed, spongy, pale tissue consisting of scattered small cysts and vesicles (Fig. 4) . The diffuse borders are commonly not well delineated from the adjacent liver tissue. A central necrotic cavity is often found in the advanced stage of hepatic alveolar echinococcosis. The lesions may be allied with focal zones of calcification. Microscopically, there is evidence of a vigorous proliferation of fibrous and germinative tissue in the periphery of the metacestode but also there are regressive changes centrally. In contrast to infection in rodent hosts, lesions from infected humans rarely exhibit protoscolices, brood capsules, and calcareous corpuscles within vesicles and cysts. At diagnosis of human alveolar echinococcosis, the nonspecific clinical symptoms usually include mild upper-quadrant and epigastric pain, possible hepatomegaly, and obstructive jaundice.
Occasionally, the initial manifestations are caused by metastases localized in the lungs or other organs (7, 109, 110) . As in cystic echinococcosis, few data on the overall prevalence of human alveolar echinococcosis exist. Cases in the native Eskimo population at risk in western Alaska, including St. Lawrence Island, have been diagnosed at an average annual rate of 28/100,000 inhabitants (138) . In Switzerland, an annual average morbidity rate of 0.18 case per 100,000 inhabitants was reported (37) . However, in various cantons of Switzerland, annual morbidity rates are higher (between 0.2 and 0.7 case per 100,000 [122] ). Data for some areas of France, Germany, and Austria were similar (139) . However, the importance of the disease is not represented by the number of reported cases but rather by the severity of the disease in the individual patient and by a frequently lethal outcome: for cases without radical surgery, mortality was found to be 92% within 10 years after primary diagnosis (114) . In recent times, the mortality rate has significantly VOL. 5, 1992 decreased to 10 to 14%, most likely because of marked improvements in diagnosis, surgery, and chemotherapy (8) .
IMMUNOLOGY Definitive Hosts
The primary site of host-parasite interaction between the adult-stage echinococcus and its carnivorous host is the mucosa of the gastrointestinal tract. For many years, it was widely held that adult cestodes were non-or poorly immunogenic (67) . Thus, little information has been elaborated on the specific immunology of adult Echinococcus infections in definitive host animals. The structures of the adult Echinococcus worm that interact with the intestinal immune system are the scolex, the integument, and all molecules excreted or secreted by the tapeworm. For E. granulosus, there is experimental evidence for induction of an adult-stage-specific humoral immune response (44, 70) . The The diagnosis of echinococcosis is generally based on a fully developed and still proliferating metacestode, which has already induced and potentially influenced an immune response of the host (reviewed in reference 62) . Cellular and humoral immune responses in humans, in contrast to those in experimentally infected animals, can vary enormously, as evidenced, e.g., by the different patterns of parasite antigens in different patients and courses of disease (43, 82) . These disparities are likely related to human and/or parasite genetic diversity, which is unlike the uniform genetic background of most experimental animals (122) .
Investigations of cell-mediated immune response in cases of murine cystic echinococcosis have revealed polyclonal B-cell activation (25) , a marked drop of mean T-cell percentage (134) but increase in suppressor cell activity (104) , direct splenic T-lymphocyte cytotoxicity to the metacestode (135) , and impairment of the host defense potential by the formation of anti-human leukocyte antigen-reactive host antibodies (6) . Several researchers have suggested that the host's capacity for developing a parasite-specific cellular response able to eliminate the parasite may be modulated by parasite- derived effector substances (9, 36, 82) . Local immune modulation by the parasite has been shown to enhance susceptibility to mycobacterial infections close to the site of parasite lesions (39) .
With regard to alveolar echinococcosis, most human patients develop parasite-specific serum antibodies, including all isotypes of immunoglobulins; very few patients fail to demonstrate a humoral immune response (52, 60) . Antibodies are thought to be involved in immunopathological mechanisms responsible for the occasional chronic granulomatous course of the disease, including immune complex-associated membranous nephropathy (98) and histopathological changes related to the incidence of amyloid and immune complex deposits in the liver, as was found in several Alaskan patients (2) .
Most patients show a specific response of peripheral blood mononuclear cells to in vitro stimulation with parasite antigen (17, 54) . Information addressing potential immunological events at the site of host-parasite interplay has shown that the periparasitic granuloma in regressive courses of disease is mainly composed of macrophages, myofibroblasts, T cells, and a large number of CD4+ lymphocytes (131 For primary serological diagnosis and for support of clinical diagnosis of echinococcosis, the selection of a particular immunodiagnostic test involves consideration of the diagnostic operating characteristics of the technique and the purpose for which it will be used. The diagnostic sensitivity and specificity of the tests used most frequently vary according to the (i) nature, purity, and quality of the antigen, (ii) nature of the patient's immunoglobulins (isotypes, etc.) specified in the test, and (iii) sensitivity of the selected technology.
Until a few years ago, most serological tests for immunodiagnosis of both cystic and alveolar echinococcosis employed E. granulosus antigens because they could be obtained easily and because, in a very early study, E. granulosus hydatid fluid had appeared to be a better diagnostic reagent than antigens prepared from E. multilocularis (96) . Cystic echinococcosis also occurs more frequently than alveolar echinococcosis and thus has initiated more investigations in the development of homologous test systems. E. granulosus hydatid fluid antigen, which was generally available, was reported to be diagnostically relatively sensitive (75 to 94%) in the indirect hemagglutination test (11, 64, 113) .
One of the most specific immunodiagnostic approaches for cystic echinococcosis (E. granulosus) relies on the demonstration of serum antibodies precipitating an antigen called antigen 5 (19) by immunoelectrophoresis or similar techniques. Experimental studies indicated that antibodies to antigen 5 are among the first detectable after infection (19, 23, 142) . Diagnostic sensitivity for hepatic cystic echinococcosis has been reported to vary between 50 and 80% (see references in reference 110). Antibodies to antigen 5 also occur in the sera of human patients with neurocysticercosis (125) and alveolar echinococcosis (127) , and comparative studies showed that only 58% of Swiss patients with alveolar echinococcosis had antibodies to antigen 5 compared with 74% of patients with cystic echinococcosis (60) .
Subsequently, the antigenic components of E. granulosus responsible for the arc-5 phenomenon were investigated by various approaches that used monoclonal antibodies or immunoblotting or both (20, 35, 82, 119) (Fig. 5) . Furthermore, preliminary results had indicated some potential for using purified antigen 5 in highly sensitive techniques such as the enzyme-linked immunosorbent assay (ELISA) (65 (51) . This Eml antigen was used as a reagent for the immunodiagnosis of both cystic and alveolar echinococcosis. It became obvious that, for the diagnosis of alveolar echinococcosis, homologous E. multilocularis metacestode antigens were superior to heterologous E. granulosus antigens, especially with regard to specificity. Similar findings were described by other groups and have been reviewed by Schantz and Gottstein (110) . When crude E. multilocularis antigens are used, however, nonspecific and cross-reactions are the cause of difficulties similar to those well known with E. granulosus antigens. Subsequent research has thus addressed the question of purifying highly specific antigens from E. multilocularis. The first documented attempt used affinity chromatographic procedures to immunosorb cross-reactive antigenic components from a crude E. multilocularis metacestode antigen solution (51) . The resulting fractions (Eml and Em2 antigens) were successfully used in an ELISA to correctly differentiate 95% of patients with cystic echinococcosis from patients with alveolar echinococcosis (57) . In subsequent studies (31, 49) , the antigenic component of the Em2 antigen fraction was purified and characterized by immunochemical means, and a monoclonal antibody was raised against the Em2 antigen.
Attempts to differentiate both forms of echinococcosis serologically have also been undertaken by others (10, 75) but without full documentation of the immunodiagnostic properties of the antigens in question. Furuya et al. used
Western blotting (immunoblotting) to analyze banding patterns of serum antibodies from Japanese echinococcosis patients. They reported specific serum antibody activity against 55-and 60-kDa E. multilocularis antigens (43) . More recently, recombinant DNA technology has been used to synthesize E. granulosus and E. multilocularis antigens. These will be discussed below.
Another approach to improving the value of immunodiagnostic properties was the individual analysis of antibody classes with respect to parasite antigens. Parasite-specific immunoglobulin E (IgE) has attracted particular attention because of its well-known importance in helminthic diseases such as those caused by E. granulosus (1, 18, 34, 87, 99, 136) and E. multilocularis (52, 67, 132) .
In addition to problems of diagnostic sensitivity and specificity due to cross-reactions, there is accumulating evidence of false-positive antibody reactions not related to infections with heterologous helminth species. Such falsepositive antibody reactions have been related to malignancies (30) , the presence of anti-P1 antibodies (14) , and liver cirrhosis (66) .
Early diagnosis of persons with asymptomatic echinococcosis is considered a prerequisite for efficient management and treatment of the disease (71) . Consequently, serological screening has been offered to populations and communities in many areas. Techniques used for areas in which E. granulosus is endemic have been reviewed by Schantz and Gottstein (110) . The tests most widely used were based on detection of arc-5 (reviewed in reference 110). They demonstrated appropriate specificity in that most arc-5-positive persons could subsequently be shown to harbor hydatid cysts (21, 126) . However, many studies have clearly demonstrated the limits of using serology alone in epidemiology, especially in areas where seropositivity is low among patients with cystic echinococcosis, such as the Turkana district in Kenya (28) . Recent (53) . Similar findings were reported from Alaskan studies (77) . In general, the epidemiological situation of low prevalence for both cystic and alveolar echinococcosis requires high diagnostic sensitivity and high species specificity, so that positive and negative predictive values result in justifiable clinical investigation of seropositive individuals. Seroepidemiological studies in Alaska have shown that Em2 ELISA detected not only asymptomatic cases of human alveolar echinococcosis serologically negative by other techniques (58) but also unique cases in which the metacestode had died out at an apparently early stage of infection (102) . This finding of spontaneous rejection of the infection may provide valuable information for future research in the immunology of E. multilocularis infection. Another approach used to circumvent specificity problems in seroepidemiology was Western blotting (42) , which shows the suitability of immunoblotting to confirm clinical cases of alveolar echinococcosis.
Serological tests used for postoperative monitoring of patients with cystic echinococcosis have been reviewed by Schantz and Gottstein (110) . More recent studies have emphasized determination of parasite-specific antibody isotypes (99) , but the small contribution of serology to monitoring the course of disease has been discussed and implicitly requires that serology be combined with an instrumental or imaging examination in order to provide an accurate prognosis.
Surgically treated cases of alveolar echinococcosis are usually treated postsurgically with chemotherapy. As only complete surgical removal of the entire parasite lesion offers a prospect of cure, the accurate assessment of the success of the resection is an urgent requirement in the clinical monitoring of patients. Serological tests have generally demonstrated a decrease in the concentration of parasite-specific serum antibody after successful surgery (113) . The preliminary use of Em2 ELISA indicated that anti-Em2 antibody concentrations declined dramatically within months after a successful radical operation (77) . These findings were confirmed in subsequent larger studies (59) .
An exceptional immunological situation is encountered with patients undergoing orthotopic liver transplantation (47, 89) . Serum antibodies were artifactually reduced or eliminated by abundant blood transfusions coupled with immunosuppressive therapy. Patients with remaining residual foci of extrahepatic parasite tissue had extremely high recurrence rates due to immunosuppression and interruption of chemotherapy with antiparasitic benzimidazoles (15) . Such recurrences were generally accompanied by the reappearance of anti-Echinococcus serum antibodies.
Patients with alveolar echinococcosis who received only chemotherapeutical treatment were very difficult to monitor by classical serological means (8, 60, 74, 77, 113 Antigen Detection in Patients with Echinococcosis Tests for the determination of circulating immune complexes in patients with cystic echinococcosis have been reviewed by Schantz and Gottstein (110) . Soluble E. granulosus antigens circulating in patient sera have been detected in 33 to 85% of serum samples from patients with cystic echinococcosis (27, 48) . Generally, it was suggested that the identification of circulating parasite antigens with their potential for immune complex formation in the sera of patients might be useful for monitoring the disease and might reflect more reliably than antibody titers the viability and biological activities of parasites in the host (38) . Surprisingly, circulating E. multilocularis antigens have been neglected in this respect.
Lymphoproliferative Responses in Patients
with Echinococcosis Skin tests and basophil degranulation tests have been extensively discussed and reviewed by Schantz and Gottstein (110) . Aside from these tests, remarkable developments in basic cellular immunology have attracted the attention of parasite immunologists to parasite-specific host cellular immune responses and have implied cytokine interplay at the site of parasitic lesions as well as at their peripheries (33) . In these studies, the in vitro lymphoproliferative response to E. granulosus antigen stimulation was assessed in 40 patients with cystic echinococcosis (120) . There was no correlation between serological and lymphoproliferative results. The diagnostic sensitivity of positive test reactions was 75% for both serology and lymphocyte proliferation. Finding seronegative patients with positive proliferation assay results and seropositive patients with negative proliferation assay results suggested that the lymphocyte-specific immunoassays should be used as diagnostic tests.
With regard to E. multilocularis, the relevance of cellular immune responses and reactions is suggested by the important granulomatous infiltration surrounding E. multiloculanis lesions in infected human livers (130) . The in vitro determination of lymphocyte proliferation to stimulation with E. multilocularis antigens has been proposed as a diagnostic alternative to antibody detection in patients with alveolar echinococcosis (17) . The same study addressed the parameters of E. multiloculanis-specific cellular immune response during a 2-to 4-year period of mebendazole treatment. A progressive decrease in the capacity to respond to parasitespecific lymphocyte stimulation was observed in most of the patients with regressive disease. On the other hand, an increase of stimulation indices was usually shown to be associated with a progression of the liver lesion. Gottstein et al. showed that the in vitro lymphoproliferative response to E. multilocularis antigen stimulation was very high in cured patients who had radical surgery or in patients with inactive lesions, but the response was significantly lower in patients who had had partial or no surgical resection (54) . Distinct differences in the parasite-specific humoral and cellular immune status of patients with self-limited infections and VOL. 5, 1992 (31) . The value of the test consequently related to (i) the reliable identification of fox populations with or without E. multilocularis infections and (ii) the estimation of the prevalence of infection within the fox populations by extrapolation. Thus, the test may be valuable in sequentially assessing the dynamics of prevalence in areas undergoing control campaigns (50) .
Alternatives to the coprological or serological diagnosis of adult-stage Echinococcus infections in definitive hosts have been proposed, for example, the antibody sandwich-ELISA (32) . Affinity-purified polyclonal antibodies raised against excretory and secretory antigens of adult-stage tapeworms were used to develop an ELISA that permitted the detection of coproantigens from E. granulosus and E. multilocularis in dog or fox fecal samples. The absence of cross-reactions with antigens related to most infections with other cestodes or nematodes proved to be genus specific. Conversely, the sensitivity was relatively low in that only hosts with a high intestinal burden of tapeworms (>1,000 Echinococcus worms per animal) reacted positively.
Another immunological diagnostic approach has been developed to identify the generic origin of taeniid eggs by using monoclonal antioncosphere antibodies (27 (45) . The subsequent gene expression system selected for the production of diagnostic antigens resulted in the synthesis of glutathione S-transferase fusion proteins. One of the fusion proteins investigated had demonstrated high specificity (100%), although its diagnostic sensitivity was low. Screening an identical library with sera from patients with cystic echinococcosis resulted in the finding of several clones with production of diagnostically highly sensitive fusion proteins (81) . The diagnostically misleading reactivity of patient antibodies with glutathione S-transferase from the fusion proteins might be circumvented by using a modified gene expression system (pGEX2), which allows cleavage of the recombinant parasite polypeptide from the glutathione S-transferase (121) . The cloning of an E. granulosus gene encoding an antigen 5 component has already been mentioned above (40) .
The first published E. multilocularis cDNA library was constructed by Vogel et al. (128) , who also used the Escherichia coli expression vector Agtll. An identified E. multilocularis species-specific recombinant clone, 11/3, demonstrated optimal immunodiagnostic characteristics, as assayed by Western blotting. Poor bacterial expression and lack of an appropriate purification protocol hampered the application of the respective antigen in routine diagnosis. This problem was solved by shortening the initial 1.0-kb cDNA sequence encoding for the antigen 11/3 to a 0.6-kb fragment and then subcloning it into plasmid vector pAR3038 (94) . The resulting increased bacterial production allowed efficient biochemical purification of the recombinant antigen II/3-10. In the pAR3038 vector, the recombinant antigen II/3-10 was synthesized as a polypeptide fused to a short (11-amino-acid) N-terminal peptide of bacteriophage T7 origin. This short phage peptide was shown to be immunologically irrelevant and thus needed no further modification prior to investigation by ELISA. A preliminary diagnostic evaluation of the recombinant antigen II/3-10 by ELISA resulted in operating characteristics suitable for immunodi-agnosis of alveolar echinococcosis in humans. The production of other recombinant E. multilocularis antigens with immunodiagnostic potential has been reported subsequently (41, 63) . Recent comparative experimental results have shown sequence homology between the recombinant antigen 11/3 described by Vogel et al. (128) and antigen EmlO described by Frosch et al. (41) .
In expression systems such as those given above for the production of E. granulosus or E. multiloculanis recombinant antigens, the products usually accumulate within the bacterial cell as a soluble protein or as insoluble precipitates.
Consequently, alternative systems such as the insertion of Echinococcus genes into the mglB gene of plasmid pVB2 have been proposed (115) . Resulting fusion proteins are linked to the mglB-encoded periplasmic galactose-binding protein, which is excreted into the periplasmic space (95 (105) . The diagnostic application of the E. multilocularis PCR putatively addressed the identification of fine-needle biopsy material obtained from patients with liver lesions of unknown etiology, the rapid and easy identification of E. multilocularis liver lesions from rodents in epidemiological studies, and, perhaps the most promising and important approach, the demonstration and identification of adult-stage parasite tissue, DNA, or eggs in samples derived from feces, small intestines, or anal swabs of definitive carnivore hosts.
